United Kingdom Biotechnology & Medical Research

Bioventix PLC (BVXP)

Track

Track

Bioventix PLC experienced recent insider trading activity characterized by a net purchase of 12,683.67 GBP. Chief Financial Officer Bruce Hiscock executed the primary acquisition during the last ninety days. Despite an 11.4% decline in stock value over this period, leadership maintains buying momentum following the previous results financiers.
Ticker: BVXP Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bioventix PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
182.31
Quantity 76,186
Value £4,423,632
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
62.79
Quantity 96,499
Value £2,187,189
Ian Nicholson Non-Executive Chairman Director
Transaction date
Purchase
Price
390.80
Quantity 13,100
Value £315,273
Peter Harrison Chief Executive Officer Officer
Through Abigail Harrison, a closely affiliated person
Transaction date
Purchase
Price
0.02
Quantity 1,065
Value £20
Peter Harrison Chief Executive Officer Officer
Transaction date
Purchase
Price
0.02
Quantity 1,065
Value £20
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
16.22
Quantity 126
Value £2,044
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
0.14
Quantity 150
Value £21
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
32.73
Quantity 61
Value £1,997
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
38.55
Quantity 24
Value £925
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
33.30
Quantity 300
Value £9,990
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
0.04
Quantity 11
Value £0
Peter Harrison Chief Executive Officer Officer
Transaction date
Sale
Price
42.00
Quantity 62,000
Value £2,604,000
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
39.77
Quantity 17
Value £676
Ian Nicholson Chairman Director
Transaction date
Sale
Price
36.52
Quantity 1,638
Value £59,812
Bruce Hiscock Chief Financial Officer Officer
Transaction date
Purchase
Price
3.48
Quantity 11
Value £38
Catherine Nicholson Chairman Director
Through Ian Nicholson, a closely affiliated person
Transaction date
Sale
Price
39.15
Quantity 1,500
Value £58,725
Ian Nicholson Chairman Director
Transaction date
Sale
Price
38.77
Quantity 1,000
Value £38,770
Nicholas McCooke Non-Executive Director Executive Director
Transaction date
Sale
Price
37.50
Quantity 2,752
Value £103,200
Peter Harrison Chief Executive Officer Officer
Transaction date
Sale
Price
37.50
Quantity 57,558
Value £2,158,425
Ian Nicholson Chairman Director
Transaction date
Sale
Price
37.50
Quantity 1,600
Value £60,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-24 B Purchase
Bruce Hiscock

Chief Financial Officer

Officer
76,186
182.31
£4,423,632 		76,186 182.31 £4,423,632
2026-04-28 2026-04-27 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
96,499
62.79
£2,187,189 		96,499 62.79 £2,187,189
2026-04-13 2026-04-10 B Purchase Ian Nicholson

Non-Executive Chairman

Director
13,100
390.80
£315,273 		13,100 390.80 £315,273
2026-04-08 2026-04-08 B Purchase Peter Harrison

Chief Executive Officer

Through Abigail Harrison, a closely affiliated person Officer
1,065
0.02
£20 		1,065 0.02 £20
2026-04-08 2026-04-08 B Purchase Peter Harrison

Chief Executive Officer

Officer
1,065
0.02
£20 		1,065 0.02 £20
2026-04-02 2026-04-02 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
126
16.22
£2,044 		126 16.22 £2,044
2025-11-26 2025-11-25 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
150
0.14
£21 		150 0.14 £21
2024-12-24 2024-12-23 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
61
32.73
£1,997 		61 32.73 £1,997
2024-11-22 2024-11-22 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
24
38.55
£925 		24 38.55 £925
2024-10-31 2024-10-30 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
300
33.30
£9,990 		300 33.30 £9,990
2024-04-30 2024-04-29 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
11
0.04
£0 		11 0.04 £0
2024-01-29 2024-01-29 S Sale Peter Harrison

Chief Executive Officer

Officer
62,000
42.00
£2,604,000 		62,000 42.00 £2,604,000
2023-11-28 2023-11-27 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
17
39.77
£676 		17 39.77 £676
2023-05-19 2023-05-18 S Sale Ian Nicholson

Chairman

Director
1,638
36.52
£59,812 		1,638 36.52 £59,812
2023-04-25 2023-04-24 B Purchase Bruce Hiscock

Chief Financial Officer

Officer
11
3.48
£38 		11 3.48 £38
2023-03-31 2023-03-31 S Sale Catherine Nicholson

Chairman

Through Ian Nicholson, a closely affiliated person Director
1,500
39.15
£58,725 		1,500 39.15 £58,725
2023-03-31 2023-03-31 S Sale Ian Nicholson

Chairman

Director
1,000
38.77
£38,770 		1,000 38.77 £38,770
2023-01-31 2023-01-31 S Sale Nicholas McCooke

Non-Executive Director

Executive Director
2,752
37.50
£103,200 		2,752 37.50 £103,200
2023-01-31 2023-01-31 S Sale Peter Harrison

Chief Executive Officer

Officer
57,558
37.50
£2,158,425 		57,558 37.50 £2,158,425
2023-01-31 2023-01-31 S Sale Ian Nicholson

Chairman

Director
1,600
37.50
£60,000 		1,600 37.50 £60,000
Explore more

More insider trading research around Bioventix PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe